The Prevalence and Incidence of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Depression and Bipolar Disorder: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Objective: The increased prevalence and incidence of affective disorders among patients with gastrointestinal disease have been well established. However, few studies have investigated the inverse relationship. We aimed to identify all pieces of evidence of the prevalence and incidence of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) in people with depression and bipolar disorder. Methods: We conducted a systematic review of studies reporting the association between affective disorders (exposure) and IBS or IBD (outcome) in adults. Evidence was evaluated for quality using Joanna Briggs Institute Critical Appraisal tools. Where suitable data were available, meta-analyses were performed. Results: We identified 18 studies that met the selection criteria, of which 11 provided data on IBS, 5 on IBD, and 2 on both. Overall, people with depression were significantly more likely to have comorbid IBS (risk ratio = 2.42, 95% confidence interval = 1.98–2.96) and to develop new-onset IBS (risk ratio = 1.90, 95% confidence interval = 1.41–2.56) compared with people without depression. They were also more likely to have and develop IBD, and among patients with IBD, significantly increased rates of depression were observed as early as 5 years before diagnosis. Bipolar disorder was not consistently associated with risk of either condition. Conclusions: People with depression are at an increased risk of both having and developing lower gastrointestinal disorders. These findings have important implications for how we understand, manage, and prevent this comorbidity in clinical practice. Further studies are needed to improve our understanding of the relationship between bipolar disorder and bowel disease as well as the role of psychotropic medication, particularly selective serotonin reuptake inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Munn, Z., Moola, S., Lisy, K., Riitano, D., & Tufanaru, C. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000054 · Cited by 3,131 · cited 1×
“We used the Critical Appraisal Checklist for Prevalence Studies (9 criteria) (32) and the Critical Appraisal Checklist for Cohort Studies (11 criteria) (33) developed by the Joanna Briggs Institute, to evaluate prevalence and incidence studies, respectively.”
MethodExcess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120 · cited 2×
“Study selection criteria Studies were included if they: (1) employed an observational design (prospective cohort, retrospective cohort, cross-sectional or case-control); (2) reported the association between depression or bipolar disorder (exposure) and IBS or IBD (outcome) in terms of prevalence or incidence; (3) had…”
BackgroundMethodMultimorbidity and depression: A systematic review and meta-analysis
Read, J. R., Sharpe, L., Modini, M., & Dear, B. F. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.009 · Cited by 869
Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta-Analytic Review
Henningsen, P., Zimmermann, T., & Sattel, H. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000075977.90337.e7 · Cited by 829
Koloski, N. A., Jones, M., Kalantar, J., Weltman, M., Zaguirre, J., & Talley, N. J. (2012) · Gut · doi:10.1136/gutjnl-2011-300474 · Cited by 611 · cited 1×
“This is supported by studies investigating the order of diagnosis among patients presenting with both a gastrointestinal and an affective disorder and has also been noted for other gut disorders, such as functional dyspepsia (46,60,61).”
BackgroundDepression and anxiety in patients with Inflammatory Bowel Disease: a systematic review
Neuendorf, R., Harding, A., Stello, N., Hanes, D., & Wahbeh, H. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.06.001 · Cited by 561 · cited 1×
“A significant body of research has established that patients with IBS and IBD experience higher rates of depression, with recent reviews suggesting a threefold increase in odds among those diagnosed with IBS compared with healthy counterparts (19) and a two to four times increase among those with IBD compared with gen…”
BackgroundFord, A. C., Lacy, B. E., Harris, L. A., Quigley, E. M. M., & Moayyedi, P. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0222-5 · Cited by 467 · cited 2×
“For example, psychological therapy has an important role in the treatment of IBS (14), such that current psychological therapies for depression could be broadened to account for comorbid GI symptoms.”
BackgroundWalker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01980.x · Cited by 437 · cited 4×
“Conversely, a smaller crosssectional study of patients with IBD (n = 351) and matched controls (n = 779) found a lower rate of lifetime prevalence of bipolar disorder in the IBD group, even though this was not statistically significant (52).”
BackgroundInfluentialBiomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415 · cited 1×
“Regarding shared etiology, immune dysfunction with a chronic inflammatory state, a defining feature of IMID, is also a well-established feature of depression (65) and a shared pathological process across multiple psychiatric disorders (66).”
BackgroundSelf-citationBulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Cited by
Chen, D., Zhang, Y., Huang, T., & Jia, J. (2023) · Psychological Medicine · doi:10.1017/s0033291723000867 · Cited by 52
“…evidence from numerous studies, including systematic reviews (Aziz, Kumar, Muhammad Nawawi, Raja Ali, & Mokhtar, 2021) and meta-analyses (Nikolova et al., 2022; Sibelli et al., 2016; Zamani, Alizadeh-Tabari, & Zamani, 2019), case reports (Li et al., 2022), and animal study (Takajo et…”
BackgroundHinnant, L., Rios Villacorta, N., Chen, E., Bacchus, D., Dotson, J., Greywoode, R., Keefer, L., Lupe, S., Maggs, L., Meek, G., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae151 · Cited by 31
Wang, Z., Wang, X., Zhao, X., Hu, Z., Sun, D., Wu, D., & Xing, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.970933 · Cited by 10
Wang, F., Liu, Y.-L., Jiang, C.-H., Wu, H.-Y., Jin, J., Sun, Y.-W., He, Z.-X., Kang, L., & Fang, X. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.030 · Cited by 8
Metadata
- Authors
- Nikolova, V. L., Pelton, L., Moulton, C. D., Zorzato, D., Cleare, A. J., Young, A. H., & Stone, J. M.
- Venue
- Psychosomatic Medicine
- Published
- 2022-01-24
- Volume
- 84
- Issue
- 3
- Pages
- 313-324
- ISSN
- 0033-3174 (ISSN-L)
- 1534-7796
- OpenAlex
- W4207032253
- Cited by
- 40
- References
- 21
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Prevalence and Incidence of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Depression and Bipolar Disorder: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1097/psy.0000000000001046
- The paper
- Nikolova, V. L., Pelton, L., Moulton, C. D., Zorzato, D., Cleare, A. J., Young, A. H., & Stone, J. M. (2022). The Prevalence and Incidence of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Depression and Bipolar Disorder: A Systematic Review and Meta-Analysis. Psychosomatic Medicine. https://doi.org/10.1097/psy.0000000000001046
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.